Second-line chemotherapy in advanced and metastatic CRC

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Roqué I Figuls, Marta ^a   Sola I ^b   Bonfill, X ^b   Martin Richard, M ^b   Lopez, J J ^b   Ginesta, I ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; PLACEBO;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLORECTAL CANCER; DRUG EFFICACY; HUMAN; METASTASIS; OUTCOME ASSESSMENT; REVIEW; SENSITIVITY ANALYSIS; TREATMENT RESPONSE;

EID: 44949214815     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006875     Document Type: Review

References (15)

1. ACS 2001 American Cancer Society. Cancer facts and figures 2001. http://www.cancer.org/docroot/STT/content/STT_1x_2001_Facts_and_Figures.pdf.asp.
2. Ahmed 2004 Ahmed N, Ahmedzai SH, Vora V, Hillam S, Paz S. Supportive care for patients with gastrointestinal cancer. Cochrane Database of Systematic Reviews 2004, Issue 3.Art. No.: CD003445. DOI:10.1002/ 14651858.CD003445.pub2.[MEDLINE: Art. No.: CD003445. DOI: 10.1002/14651858.].
3. CTCAE Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/reporting/ctc.html.
4. Cunningham 1998 Cunningham D, Pyrhönen S, James RD, Punt CJA, Hickish TF, Heikkila R, et al.Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352:1413-8.
5. Deeks 2005 Deeks JJ, Higgins, JPT, Altman DG, editors. Analysing and presenting results. In: HigginsJPT, GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. Section 8. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd, 2005.
6. GLOBOCAN 2002 GLOBOCAN 2002. http://www.dep.iarc.fr. http://www.dep.iarc.fr.
7. Higgins 2005 Higgins JPT, Green S, editors. Locating and selecting studies for reviews. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 4. The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons, Ltd, 2005.
8. Michael 2003 Michael M, Zalcberg JR. The treatment of carcinoma of the colon and rectum. In: WilliamsC editor(s). Evidence-based Oncology. London: BMJ Books, 2003, 48-52, 2003.
9. NCCN NCCN. National Comprehensive Cancer Network. http://www.nccn.org.
10. Ng 2003 Ng RCH, Fitzharris BM, Hider PN, Jeffery GM. Chemotherapy with platinum compounds for metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2003, Issue 1.DOI:10.1002/14651858.
11. NICE 2005 Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (review). http://www.nice.org.uk/TA093.pdf.
12. Parmar 1998 Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34.
13. Therasse 2000 Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000 Feb 2;92(3):205-16.
14. Wagner 2005 Wagner AD, Arnold D, Behl S, Fleig WE, Haerting J. Anti-angiogenic therapy for metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2005, Issue 2.DOI:10.1002/14651858..
15. WHO 1979 World Health Organization. Handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization, 1979: 15-22.